Tocotrienols have a nephroprotective action against lipid-induced chronic renal dysfunction in rats

Renal Failure

Volumn 37, Issue 1, 2015, Pages 136-143

  Rashid Khan, Mohammad ^a,c   Ahsan, Haseeb ^b   Siddiqui, Shabeena ^a   Siddiqui, Waseem A ^a  

^a HAMDARD UNIVERSITY   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Chronic renal dysfunction; Dyslipidemia; Nephropathy; Proteinuria; Tocotrienols

Indexed keywords

ALPHA TOCOTRIENOL; CHOLESTEROL; CHOLIC ACID; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PALM OIL; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT; EDIBLE OIL; FREE RADICAL; PLANT MEDICINAL PRODUCT; PROTECTIVE AGENT; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BEEF; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; HYPERLIPIDEMIA; HYPOLIPEMIA; KIDNEY FUNCTION; LIPID OXIDATION; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; RENAL PROTECTION; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; ANIMAL; COMPLICATION; DISEASE MODEL; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; METABOLISM; PROCEDURES; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DIETARY FATS, UNSATURATED; DISEASE MODELS, ANIMAL; FREE RADICALS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; PLANT OILS; PLANT PREPARATIONS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TOCOTRIENOLS; TREATMENT OUTCOME;

EID: 84919449590     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.959433     Document Type: Article

References (33)

1. Agarwal A, Balla J, Balla G, Croatt AJ, Vercellotti GM, Nath KA. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol. 1996;271:F814-F823.
2. Stulak JM, Lerman A, Porcel MR, et al. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol. 2001;12:1882-1891.
3. Chade AR, Rodriguez-Porcel M, Grande JP, et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol. 2003;23: 1295-1301.
4. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res. 2000;87:349-354.
5. Lee HS, Jeong, JY, Kim BC, Kim YS, Zhang YZ, Chung HK. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int. 1997;51:1151-1159.
6. Eddy AA. Interstitial fibrosis in hypercholesterolemic rats: Role of oxidation, matrix synthesis, and proteolytic cascades. Kidney Int. 1998;53:1182-1189.
7. Kasiske BL, O'Donnel MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int. 1988;33:667-672.
8. Sen CK, Khanna S, Roy S. Tocotrienol: The natural vitamin E to defend the nervous system? Ann NY Acad Sci. 2004;1031:127-142.
9. Sen CK, Khanna S, Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 2006;78:2088-2098.
10. 7)-induced acute renal injury in rats. Chem Biol Interact. 2010;186: 228-238.
11. Siddiqui S, Khan MR, Siddiqui WA. Comparative hypoglycemic and nephroprotective effects of tocotrienol rich fraction (TRF) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats. Chem Biol Interact. 2010; 188:651-658.
12. Husain K, Francois RA, Hutchinson SZ, et al. Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration. Pharmacology. 2009;83:157-163.
13. Mei HN, Yuen MC, Cheng HC, Hashim MA. Separation of vitamin E (tocopherol, tocotrienol and tocomonoenol) in palm oil. Lipids. 2004;39:1031-1035.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502.
15. Deepa PR, Varalakshmi P. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clin Chim Acta. 2004;339(1-2):105-115.
16. Arreola-Mendoza L, Reyes JL, Melendez E, et al. Alpha-tocopherol protects against the renal damage caused by potassium dichromate. Toxicology. 2006;218:237-246.
17. Utley HC, Bernheim F, Hachslein P. Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys. 1967;260: 521-531.
18. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophoto-metric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5:62-71.
19. Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
20. 7. Free Radic Biol Med. 2003;34:1390-1398.
21. Iqbal J, Minhajuddin M, Beg ZH. Suppression of 7, 12-dimethylbenz [alpha] anthracene-induced carcinogenesis and hypercholesterolaemia in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur J Can Prev. 2003;12:447-453.
22. Tanaka M, Nakaya S, Kumai T, Watanabe M, Matsumoto N, Kobayashi S. Impaired testicular function in rats with dietinduced hypercholesterolemia and/or streptozotocin-induced diabetes mel-litus. Endocrine Res. 2001;27:109-117.
23. Danda RS, Habiba NM, Rincon-Choles H, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int. 2005; 68:2562-2571.
24. Domingues JH, Tang N, Xu W. Studies of renal injury III: Lipid-induced nephropathy in type II diabetes. Kidney Int. 2000;57: 92-104.
25. Anderson S, King AJ, Brenner BM. Hyperlipidemia and glomerular sclerosis. An alternative viewpoint. Am J Med. 1989;87:34N-38N.
26. Uhlig K, Levey AS, Sarnak MJ. Traditional cardiac risk factors in individuals with chronic kidney disease. Semin Dial. 2003;16: 118-127.
27. Campese VM, Bianchi S, Bigazzi R. Association between hyper-lipidemia and microalbuminuria in essential hypertension. Kidney Int. 1999;71:S10-S13.
28. Takemura T, Yoshioka K, Aya N, et al. Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int. 1993;43:918-927.
29. Magil AB. Interstitial foam cells and oxidized lipoprotein in human glomerular disease. Mod Pathol. 1999;12:33-40.
30. Coritsidis G, Rifici V, Gupta S, et al. Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int. 1991;39:858-866.
31. Rovin BH, Tan LC. LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int. 1993;43:218-225.
32. Gupta S, Rifici V, Crowley S, Brownlee M, Shan Z, Schlondorff D. Interactions of LDL and modified LDL with mesangial cells and matrix. Kidney Int. 1992;141:1161-1169.
33. Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. Effect of statins versus untreated dyslipidemia on renal function in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. J Clin Pathol. 2004;57:728-734.